NCT05387512 2026-04-06
Real-world Association Between Concomitant Beta-blocker Exposure and Anti-PD-1/PD-L1 Treatment Outcomes in Advanced Non-Small Cell Lung Cancer
Affiliated Hospital of Nantong University
Completed
Clinical Trials
11 trialsNCT05312255 2025-12-01
Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma
Roswell Park Cancer Institute
Phase NA Recruiting
NCT06839144 2025-07-11
OC-POP-PT
Tel-Aviv Sourasky Medical Center
Phase 2 Recruiting
NCT05972785 2024-08-21
Long-term Use of CCB and Breast Cancer Risk
Curtin University
Active not recruiting
NCT01873131 2023-11-02
A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn
Massachusetts General Hospital
Phase NA Recruiting
NCT02818517 2022-02-02
Evaluation and Management of Cardio Toxicity in Oncologic Patients
Tel-Aviv Sourasky Medical Center
Recruiting
NCT02907021 2020-10-09
SCHOLAR
Population Health Research Institute
Phase 1 Completed
NCT01908972 2018-12-19
The Safety and Efficiency of Propranolol as an Initial Treatment for Pediatric Hemangioma
Seoul National University Hospital
Phase 4 Completed
NCT01544959 2018-10-24
PAINFree
Université de Sherbrooke
Phase NA Completed
NCT01072045 2014-12-02
Comparative Study of the Use of Beta Blocker and Oral Corticosteroid in the Treatment of Infantile Hemangioma
University of Sao Paulo
Phase 2 Completed
NCT02215733 2014-08-13
The Use of Angiotensin Receptor Blockers and the Risk of Cancer
Boehringer Ingelheim
Completed